[Code of Federal Regulations]
[Title 16, Volume 2]
[Revised as of January 1, 2007]
From the U.S. Government Printing Office via GPO Access
[CITE: 16CFR1115.12]

[Page 164-165]
 
                     TITLE 16--COMMERCIAL PRACTICES
 
             CHAPTER II--CONSUMER PRODUCT SAFETY COMMISSION
 
PART 1115_SUBSTANTIAL PRODUCT HAZARD REPORTS--Table of Contents
 
                    Subpart A_General Interpretation
 
Sec.  1115.12  Information which should be reported; evaluating 
substantial product hazard.

    (a) General. Subject firms should not delay reporting in order to 
determine to a certainty the existence of a reportable noncompliance, 
defect or unreasonable risk. The obligation to report arises upon 
receipt of information from which one could reasonably conclude the 
existence of a reportable noncompliance, defect which could create a 
substantial product hazard, or unreasonable risk of serious injury or 
death. Thus, an obligation to report may arise when a subject firm 
received the first information regarding a potential hazard, 
noncompliance or risk. (See Sec.  1115.14(c).) A subject firm in its 
report to the Commission need not admit, or may specifically deny, that 
the information it submits reasonably supports the conclusion that its 
consumer product is noncomplying, contains a defect which could create a 
substantial product hazard within the meaning of section 15(b) of the 
CPSA, or creates an unreasonable risk of serious injury or death. After 
receiving the report, the staff may conduct further investigation and 
will preliminarily determine whether the product reported upon presents 
a substantial product hazard. This determination can be based on 
information supplied by a subject firm or from any other source. If the 
matter is adjudicated, the Commission will ultimately make the decision 
as to substantial product hazard or will seek to have a court make the 
decision as to imminent product hazard.
    (b) Failure to comply. A subject firm must report information 
indicating that a consumer product which it has distributed in commerce 
does not comply with an applicable consumer product safety standard or 
ban issued under the CPSA, or a voluntary consumer product safety 
standard upon which the Commission has relied under section 9 of the 
CPSA.
    (c) Unreasonable risk of serious injury or death. A subject firm 
must report when it obtains information indicating that a consumer 
product which it has distributed in commerce creates an unreasonable 
risk of serious injury or death.
    (d) Death or grievous bodily injury. Information indicating that a 
noncompliance or a defect in a consumer product has caused, may have 
caused, or contributed to the causing, or could cause or contribute to 
the causing of a death or grievous bodily injury (e.g., mutilation, 
amputation/dismemberment, disfigurement, loss of important bodily 
functions, debilitating internal disorders, severe burns, severe 
electrical shocks, and injuries likely to require extended 
hospitalization) must be reported, unless the subject firm has 
investigated and determined that the information is not reportable.
    (e) Other information indicating a defect or noncompliance. Even if 
there are no reports of a potential for or an actual death or grievous 
bodily injury, other information may indicate a reportable defect or 
noncompliance. In evaluating whether or when a subject firm should have 
reported, the Commission will deem a subject firm to know what a 
reasonable and prudent manufacturer (including an importer), 
distributor, or retailer would know. (See Sec.  1115.11.)
    (f) Information which should be studied and evaluated. Paragraphs 
(f)(1) through (7) of this section are examples of information which a 
subject firm should study and evaluate in order to determine whether it 
is obligated to report under section 15(b) of the CPSA. Such information 
may include information that a firm has obtained, or reasonably should 
have obtained in accordance with Sec.  1115.11, about product use, 
experience, performance, design, or manufacture outside the United 
States that is relevant to products sold or distributed in the United 
States. All information should be evaluated to determine whether it 
suggests the existence of a noncompliance, a defect, or an unreasonable 
risk of serious injury or death:

[[Page 165]]

    (1) Information about engineering, quality control, or production 
data.
    (2) Information about safety-related production or design change(s).
    (3) Product liability suits and/or claims for personal injury or 
damage.
    (4) Information from an independent testing laboratory.
    (5) Complaints from a consumer or consumer group.
    (6) Information received from the Commission or other governmental 
agency.
    (7) Information received from other firms, including requests to 
return a product or for replacement or credit. This includes both 
requests made by distributors and retailers to the manufacturer and 
requests from the manufacturer that products be returned.
    (g) Evaluating substantial risk of injury. Information which should 
be or has been reported under section 15(b) of the CPSA does not 
automatically indicate the presence of a substantial product hazard. On 
a case-by-case basis the Commission and the staff will determine whether 
a defect or noncompliance exists and whether it results in a substantial 
risk of injury to the public. In deciding whether to report, subject 
firms may be guided by the following criteria the staff and the 
Commission use in determining whether a substantial product hazard 
exists:
    (1) Hazard created by defect. Section 15(a)(2) of the CPSA lists 
factors to be considered in determining whether a defect creates a 
substantial risk of injury. These factors are set forth in the 
disjunctive. Therefore, the exist- ence of any one of the factors could 
create a substantial product hazard. The Commission and the staff will 
consider some or all of the following factors, as appropriate, in 
determining the substantiality of a hazard created by a product defect:
    (i) Pattern of defect. The Commission and the staff will consider 
whether the defect arises from the design, composition, contents, 
construction, finish, packaging, warnings, or instructions of the 
product or from some other cause and will consider the conditions under 
which the defect manifests itself.
    (ii) Number of defective products distributed in commerce. Even one 
defective product can present a substantial risk of injury and provide a 
basis for a substantial product hazard determination under section 15 of 
the CPSA if the injury which might occur is serious and/or if the injury 
is likely to occur. However, a few defective products with no potential 
for causing serious injury and little likelihood of injuring even in a 
minor way will not ordinarily provide a proper basis for a substantial 
product hazard determination. The Commission also recognizes that the 
number of products remaining with consumers is a relevant consideration.
    (iii) Severity of the risk. A risk is severe if the injury which 
might occur is serious and/or if the injury is likely to occur. In 
considering the likelihood of any injury the Commission and the staff 
will consider the number of injuries reported to have occurred, the 
intended or reasonably foreseeable use or misuse of the product, and the 
population group exposed to the product (e.g., children, elderly, 
handicapped).
    (iv) Other considerations. The Commission and the staff will 
consider all other relevant factors.
    (2) Hazard presented by noncompliance. Section 15(a)(1) of the CPSA 
states that a substantial product hazard exists when a failure to comply 
with an applicable consumer product safety rule creates a substantial 
risk of injury to the public. Therefore, the Commission and staff will 
consider whether the noncompliance is likely to result in injury when 
determining whether the noncompliance creates a substantial product 
hazard. As appropriate, the Commission and staff may consider some or 
all of the factors set forth in paragraph (f)(1) of this section in 
reaching the substantial product hazard determination.

[43 FR 34998, Aug. 7, 1978, as amended at 57 FR 34229, Aug. 4, 1992; 66 
FR 54925, Oct. 31, 2001; 71 FR 42031, July 25, 2006]